Robert Goodenow

Robert Goodenow

No open positions remaining
76 year
Health Technology
Consumer Services
Miscellaneous

Profile

Robert S.
Goodenow
is currently the Chief Executive Officer at Alanis Therapeutics, Inc. He previously worked as a Principal at Baxter International, Inc., Head-Oncology Business Development at Aventis, Inc., Secretary & Chief Business Officer at Syndax Pharmaceuticals, Inc., and Chief Business Officer at HUYA Bioscience International LLC.
From 2002 to 2007, he served as the Vice President-Corporate Development at Inovio Pharmaceuticals, Inc. Dr. Goodenow holds a doctorate degree from Stanford University and an undergraduate degree from the University of California, Berkeley.

Robert Goodenow active positions

CompaniesPositionStart

Former positions of Robert Goodenow

CompaniesPositionEnd
INOVIO PHARMACEUTICALS, INC. Corporate Officer/Principal 15/03/2007
President -
BAXTER INTERNATIONAL INC. Corporate Officer/Principal -
Corporate Officer/Principal -
SYNDAX PHARMACEUTICALS, INC. Corporate Officer/Principal -
See the detail of Robert Goodenow's experience

Training of Robert Goodenow

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

10

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Miscellaneous

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Robert Goodenow